News

Octapharma will invest 85M € in Alsace by 2024

Located since 20 years in Strasbourg with more than 650 employees, Octapharma, specialized in blood plasma manufacturing, will invest 85M € by 2024 to double its immunoglobulin production capacity, to increase its workforce and expand its storage site.  

Located since 20 years in Strasbourg with more than 650 employees, Octapharma, specialized in blood plasma manufacturing, will invest 85M € by 2024 to double its immunoglobulin production capacity, to increase its workforce and expand its storage site.

 

Share this article
Google +
email
fr_FR